CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CiToxLAB Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10681
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CiToxLab Group (CiToxLab) is a contract research organization that provides preclinical and specialty services. The company provides toxicology and safety pharmacology, biomarkers, pharmacokinetics, immunology services, surgical models and medical device implantation, animal efficacy models, preclinical and clinical genomics and biodistribution services. CiToxLab also offers support services for the development of candidate pharmaceuticals and biopharmaceuticals in the areas of biologicals, hormones, small molecules, vaccines, gene therapy vectors, biosimilars and others. The company caters its services to pharmaceutical, chemicals, food, cosmetics, biotechnology and medical devices companies. It has a presence in France, Denmark, Hungary and North America. CiToxLab is headquartered in Evreux, France.

CiToxLAB Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CiToxLAB Group, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
CiToxLAB Acquires New Facility for Bioanalysis and Biomarkers Services 11
Partnerships 12
Citoxlab Enters into Partnership with Experimental Pharmacology and Oncology Berlin-Buch 12
Acquisition 13
Citoxlab to Acquire Solvo Biotech 13
CiToxLAB Acquires Xenometrics 14
CiToxLAB Acquires AccelLAB 15
CiToxLAB Group – Key Competitors 16
CiToxLAB Group – Key Employees 17
CiToxLAB Group – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Aug 30, 2018: Citoxlab names Christophe Berthoux as CEO, Europe 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
CiToxLAB Group, Pharmaceuticals & Healthcare, Key Facts 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
CiToxLAB Acquires New Facility for Bioanalysis and Biomarkers Services 11
Citoxlab Enters into Partnership with Experimental Pharmacology and Oncology Berlin-Buch 12
Citoxlab to Acquire Solvo Biotech 13
CiToxLAB Acquires Xenometrics 14
CiToxLAB Acquires AccelLAB 15
CiToxLAB Group, Key Competitors 16
CiToxLAB Group, Key Employees 17
CiToxLAB Group, Other Locations 18
CiToxLAB Group, Subsidiaries 18

List of Figures
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CiToxLAB Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CiToxLAB Group, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[CiToxLAB Group:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chicago Bridge & Iron Company N.V.:企業の戦略・SWOT・財務情報
    Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report Summary Chicago Bridge & Iron Company N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • China Railway Group Ltd:戦略・SWOT・企業財務分析
    China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report Summary China Railway Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidia …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • FMC Corp (FMC):企業の財務・戦略的SWOT分析
    FMC Corp (FMC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • FirstString Research Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary FirstString Research Inc (FirstString) is a biopharmaceutical company that discovers and develops therapies for inflammation and injury based medical conditions. The company markets new therapeutic products that enable physicians to treat unmet medical need. It offers therapeutic approach, w …
  • TransCanada Corp (TRP):石油・ガス:M&Aディール及び事業提携情報
    Summary TransCanada Corp (TransCanada) is an energy infrastructure company. It develops and operates energy infrastructure, such as natural gas and liquids pipelines, power generation and gas storage facilities. The company also provides gas storage related services and operates in the regulated and …
  • CA Technologies, Inc.:企業の戦略・SWOT・財務情報
    CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary CA Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • American Caresource Holdings Inc (GNOW)-製薬・医療分野:企業M&A・提携分析
    Summary American Caresource Holdings Inc (ACS) is a healthcare service provider that offers urgent and primary care services. The center’s services include urgent care, veterans care, primary care, and occupational health services. Its urgent care services offer treatment for chest pain, abdominal p …
  • Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析
    Medidata Solutions Inc (MDSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclo …
  • Georgian Oil and Gas Corp:電力:M&Aディール及び事業提携情報
    Summary Georgian Oil and Gas Corp (GOGC) is an oil and gas corporation that explores, produces, transports, and supplies oil and gas products. The corporation offers services such as oil and gas transportation infrastructure operation, oil and gas pipelines design and construction, pipeline developm …
  • Ubiquiti Networks Inc:企業の戦略・SWOT・財務分析
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • The Williams Companies Inc (WMB):企業の財務・戦略的SWOT分析
    The Williams Companies Inc (WMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Altin Yunus Cesme Turistik Tesisler A.S.
    Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report Summary Altin Yunus Cesme Turistik Tesisler A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Blockchain Power Trust (TEP.UN):電力:M&Aディール及び事業提携情報
    Summary Blockchain Power Trust is an alternative energy company that offers power solutions. The company's services include wind energy solutions, power generations, transmission, supplying, and distribution services. It also provides solar energy solutions, and hydropower energy solutions, among ot …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Anavex Life Sciences Corp (AVXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆